Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
- DOI
- 10.1186/1476-4598-13-69
- Published
- 2014 Mar 21
- Container
- Molecular cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/1476-4598-13-69,
title = {Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.},
author = {Nuvoli B and Germoni S and Morosetti C and Santoro R and Cortese G and Masi S and Cordone I and Galati R},
year = {2014},
journal = {Molecular cancer},
doi = {10.1186/1476-4598-13-69},
url = {https://doi.org/10.1186/1476-4598-13-69}
}RIS
TY - JOUR TI - Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease. AU - Nuvoli B AU - Germoni S AU - Morosetti C AU - Santoro R AU - Cortese G AU - Masi S AU - Cordone I AU - Galati R PY - 2014 JO - Molecular cancer DO - 10.1186/1476-4598-13-69 UR - https://doi.org/10.1186/1476-4598-13-69 ER -
APA
B, N., S, G., C, M., R, S., G, C., S, M., I, C., & R, G. (2014). Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.. Molecular cancer. https://doi.org/10.1186/1476-4598-13-69
Source records
- pubmed · retrieved 2026-09-25T11:31:29.100Z